AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,285 | -42.4% | 221,850 | -7.8% | 0.87% | -44.7% |
| Q2 2023 | $3,966 | +48.7% | 240,629 | -17.3% | 1.58% | +50.6% |
| Q1 2023 | $2,667 | +20.1% | 291,113 | -6.2% | 1.05% | +24.9% |
| Q4 2022 | $2,221 | -99.9% | 310,251 | -20.6% | 0.84% | +1.8% |
| Q3 2022 | $1,958,000 | +258.6% | 390,861 | +74.7% | 0.82% | +259.8% |
| Q2 2022 | $546,000 | -61.5% | 223,780 | +7.8% | 0.23% | -49.3% |
| Q1 2022 | $1,418,000 | -32.0% | 207,663 | -19.6% | 0.45% | -36.2% |
| Q4 2021 | $2,086,000 | – | 258,198 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |